Health Tech Firms Partner to Enhance Clinical Trial Access in the UK

In a significant move to improve patient access to clinical trials, Dutch health technology company myTomorrows has announced a partnership with UK-based personal health recordkeeper Patients Know Best (PKB). This collaboration aims to simplify the process of matching patients with unmet medical needs to appropriate clinical trials and expanded access programs.

AI-Powered Trial Matching

myTomorrows, known for its clinical trial matchmaking capabilities, will leverage its artificial intelligence-driven search platform to scan for suitable trials for PKB users. The platform draws information from World Health Organization-endorsed public registries, including Clinicaltrials.gov, EudraCT, and the UK's international standard randomized controlled trial number system.

Michel van Harten, M.D., CEO of myTomorrows, emphasized the partnership's potential impact: "Through this collaboration, we aim to give patients, their families and healthcare professionals across the U.K. a simplified way of identifying the next steps in their treatment journey."

Unified Patient Records

PKB's role in this partnership involves creating comprehensive patient records by aggregating data from various sources, including hospitals, general practitioners, and mental health IT systems. This unified approach to health records will enable myTomorrows to conduct more accurate and efficient searches for relevant clinical trials.

Global Expansion

This partnership announcement follows myTomorrows' recent expansion into the Asia-Pacific region, marked by the opening of an operations hub in Delhi, India. These strategic moves underscore the company's commitment to broadening access to clinical trials on a global scale, particularly for patients with limited treatment options.

As the pharmaceutical industry continues to evolve, collaborations like this between health tech firms and medical record keepers are poised to play a crucial role in advancing patient-centric care and accelerating clinical research.